Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Prader-Willi Syndrome market. The report analyses the Global Prader-Willi Syndrome Therapeutics Market in terms of its sizing, growth and forecast. The report presents a comprehensive pipeline assessment that includes DCCR (Soleno Therapeutics), Levolitide (Millendo Therapeutics) and Tesomet (Saniona). Also, the report analyzes the prevalence of PWS and profiles the leading companies operating in the PWS Therapeutics market. The report analyzes the Global Market, European Region Market and the country analysis of United States and Japan for the historical period of 2017 and 2018 and the forecast period of 2019-2024.
According to the report, the Prader-Willi Syndrome therapeutics market is projected to display a robust growth represented by a CAGR of 4.6% during 2019 – 2024.
Over the recent years, the Prader-Willi Syndrome market has been witnessing considerable growth directly on the back of the increasing number of diagnosed patient’s population. Moreover, growing human growth hormone therapy coverage rate, surging awareness and increasing government involvement have been driving the market. Further, expected launch of novel therapies, such as DCCR (Soleno Therapeutics), Livoletide (Millendo Therapeutics), Testomet (Saniona AB) among others are anticipated to fuel the market growth.
The report titled report “Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 – 2024)” has covered and analyzed the potential of Prader-Willi Syndrome market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges, opportunities and market entry strategies for various companies. Additionally, the report also highlights the estimated prevalence of Prader-Willi Syndrome in USA, Europe and Japan.
Scope of the Report Global Prader-Willi Syndrome Market (Actual Period: 2017-2018, Forecast Period: 2019-2024) • Prader-Willi Syndrome Market – Size, Growth, Forecast • Prader-Willi Syndrome Market: Pipeline Analysis o DCCR (Soleno Therapeutics) o Levolitide (Millendo Therapeutics) o Tesomet (Saniona)
Regional Prader-Willi Syndrome Market – U.S.A, Europe, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024) • Prader-Willi Syndrome Market – Size, Growth, Forecast • Prader-Willi Syndrome Market: Pipeline Analysis o DCCR (Soleno Therapeutics) o Levolitide (Millendo Therapeutics) o Tesomet (Saniona)
Other Report Highlights • Pipeline Analysis. • Competitive Landscape. • Product Benchmarking. • Market Dynamics – Drivers and Restraints. • Market Trends. • Porter Five Forces Analysis. • SWOT Analysis. • Company Analysis – Pfizer, Novartis, Novo Nordisk, Soleno Therapeutics, Saniona
Customization of the Report The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Our reports have been used by over 10K customers, including:
192 pages •
By The Business Research Company
• Feb 2022
Alpha Mannosidosis Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global alpha mannosidosis market as it emerges from the COVID 19 shut down. Description: Where is the largest...
The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period”. The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices,...
The global digital therapeutics market is expected to grow from US$ 4,226.94 million in 2021 to US$ 18,061.79 million by 2028; it is estimated to grow at a CAGR of 23.1% from 2021 to 2028. The increasing prevalence of chronic diseases, the growing need to reduce healthcare costs, and partnerships and collaborations by companies fuel...
The hyperhidrosis treatment market studied is anticipated to grow with a CAGR of 6.2% during the forecast period. The major factors attributing to the growth of the hyperhidrosis treatment market are a rise in the prevalence of secondary hyperhidrosis conditions and an increase in investments by players for research and development. According...
The global prostate health market is projected to reach USD 48.9 billion by 2026 from USD 31.8 billion in 2021, at a CAGR of 9.0% during the forecast period. The prostate gland (the prostate) is an organ of the male reproductive system. The three most common forms of prostate disease are inflammation (prostatitis), non-cancerous enlargement...
An ear infection occurs when a bacterial or viral infection that affects the inner, middle or outer ear. Ear infections can be painful because of inflammation and fluid buildup in the ear. Acute ear infection can cause mild pain and discomfort in the ear. However chronic cases can cause severe pain, loss of body balance, drainage of fluids...
The global injection pens market is projected to reach USD 53.3 billion by 2026 from USD 37.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Growing prevalence of chronic diseases, increasing number of regulatory approvals, favourable reimbursement and government support, and technological advancements in injection pens tend...
The hematuria treatment market is projected to reach US$ 1,103.61 million by 2028 from US$ 932.89 million in 2021; it is estimated to grow at a CAGR of 2.4% from 2021 to 2028. Factors such as the high prevalence of hematuria-associated indications, and increasing awareness about treatment options and improving healthcare expenditure are driving...
Executive Summary Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market was valued at USD 5.5 billion in the year 2020. The key factors driving growth in the global Gastroesophageal Reflux Disease Therapeutics market is increased public awareness of the disease and its symptoms. The growing incidence of heartburn...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
Cardiology
Healthcare
Hospital
Health Services
Medical Device
Cancer
Therapy
World
United States
North America
APAC
Cancer Incidence
Drug Approval
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.